NewslettersHepatic Cell NewsFe3+-Binding Transferrin Nanovesicles Encapsulating Sorafenib Induce Ferroptosis in Hepatocellular CarcinomaBy Jamie Kang - July 13, 20230160In vivo and in vitro experiments revealed that SOR@TF-Fe3+ nanovesicles predominantly accumulate in the liver, and specifically targeted HCC cells overexpressing transferrin receptor.[Biomaterials Research]Full ArticleGraphical Abstract